4.6 Article

Development of an Evidence-Based, Theory-Informed National Survey of Physician Preparedness for Genomic Medicine and Preferences for Genomics Continuing Education

Journal

FRONTIERS IN GENETICS
Volume 11, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fgene.2020.00059

Keywords

survey development; genomic education; qualitative; Delphi; theory

Funding

  1. Victorian Government's Operational Infrastructure Support Program
  2. Australian National Health & Medical Research Council [GNT1113531]
  3. Helen R. Freeman Scholarship

Ask authors/readers for more resources

Despite some early implementation of genomic medicine globally, there is a lack of rigorous, large-scale assessments of medical specialists' current practice and continuing education needs. As a first step to addressing this gap, we describe the development of a robust, expert-reviewed, survey using a mixed-methods sequential study design. We conducted semi-structured qualitative interviews with 32 education providers and 86 non-genetic medical specialists about current genomic medicine practice and need for continuing education. Key concepts were identified and used as an initial framework for the survey. These were: personal characteristics (medical specialty, years of practice); current practice of genomics in clinical and research settings; perception of how proximal genomic medicine is to practice; perception of preparedness (competence and confidence); and, preferences for future roles and models of care in genomic medicine and for continuing education. Potential survey questions that related to at least one of these concepts were identified from the literature or were created if no suitable question existed. Using a modified, reactive Delphi approach, questions were reviewed by a panel of 22 experts. Experts were selected purposefully representing four areas of expertise: non-genetic medical specialties; clinical genetics; genetic/genomic education and evaluation; and implementation science. Three Delphi rounds assessed relevance, clarity and importance of each question. The questions were also mapped to the behaviour change wheel theoretical framework which encompasses capability, opportunity and motivation (COM-B). The survey (included as supplementary material) was then tested with a small group of non-genetic medical specialists and feedback was written or verbal in 'talk-aloud', cognitive interviews. The final survey was then piloted with a further 29 specialists. We describe the methodology to create a robust, data- and theory-informed survey. The final survey captures not only levels of experience, practice of genomics and preferences for education but also the challenges around engaging with education. Survey data will provide evidence for education providers to inform development of education which meets learner needs and contributes to a medical workforce that is literate in genomics and more confident to competently practice genomic medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Genetics & Heredity

Correspondence on Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG) by Gregg et al

Sarah Righetti, Lisa Dive, Alison D. Archibald, Lucinda Freeman, Belinda McClaren, Anaita Kanga-Parabia, Martin B. Delatycki, Nigel G. Laing, Edwin P. Kirk, Ainsley J. Newson

GENETICS IN MEDICINE (2022)

Article Genetics & Heredity

Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children

Ilias Goranitis, You Wu, Sebastian Lunke, Susan M. White, Tiong Y. Tan, Alison Yeung, Matthew F. Hunter, Melissa Martyn, Clara Gaff, Zornitza Stark

Summary: This study evaluates the cost-effectiveness of providing faster genomic results in pediatric critical care and finds that early initiation of ultra-rapid genomic testing can offer substantial economic and personal benefits.

GENETICS IN MEDICINE (2022)

Article Biochemistry & Molecular Biology

Genetics follow up after rapid genomic sequencing in intensive care: current practices and recommendations for service delivery

Fiona Lynch, Amy Nisselle, Zornitza Stark, Clara L. Gaff, Belinda McClaren

Summary: This study explores the preferences and perspectives of health professionals and parents regarding genetics follow-up after rapid genomic sequencing (rGS) in critically unwell children. The findings reveal that current practices surrounding genetics follow-up after rGS are highly variable, resulting in some families not receiving the ongoing care they need. Parents expressed a desire for more follow-up care, while health professionals identified organizational and psychosocial barriers to conducting follow-up.

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Article Education & Educational Research

Unearthing the Learning of Genomic Medicine in the Workplace: a Qualitative Study

Alice Kim, Amy Nisselle, Jennifer Weller-Newton, Belinda McClaren, Louise Keogh

Summary: Workplace learning is crucial for professionals to apply theoretical concepts to practice and stay updated with emerging ideas. This study explores how genomic medicine is learned in the workplace and factors influencing these learning experiences. The findings reveal various learning opportunities related to genomic medicine through established clinical work practice, contextual affordances, and personal pursuits. Barriers and facilitators impact participants' learning experiences and access to opportunities. Recognizing these informal learning opportunities is vital to ensure healthcare professionals are equipped with knowledge and confidence to engage with practice-related developments.

VOCATIONS AND LEARNING (2022)

Article Genetics & Heredity

Attitudes of Australian dermatologists on the use of genetic testing: A cross-sectional survey with a focus on melanoma

Clare A. Primiero, Amy M. Baker, Courtney K. Wallingford, Ellie J. Maas, Tatiane Yanes, Lindsay Fowles, Monika Janda, Mary-Anne Young, Amy Nisselle, Bronwyn Terrill, Jason M. Lodge, Jane M. Tiller, Paul Lacaze, Hayley Andersen, Gemma McErlean, Erin Turbitt, H. Peter Soyer, Aideen M. McInerney-Leo

Summary: This study surveyed Australian Dermatologists on the perceived utility of genetic testing and its current use in practice. It found that while most dermatologists recognized the relevance of genetic testing to future practice, the actual ordering and use of genetic tests were limited. Future educational interventions could focus on appropriate test ordering, result interpretation, and potential insurance implications.

FRONTIERS IN GENETICS (2022)

Article Genetics & Heredity

Co-design, implementation, and evaluation of plain language genomic test reports

Gemma R. Brett, Aisha Ward, Sophie E. Bouffler, Elizabeth E. Palmer, Kirsten Boggs, Fiona Lynch, Amanda Springer, Amy Nisselle, Zornitza Stark

Summary: By implementing plain language genomic test reports in real-world settings through co-design, patient/family and caregiver understanding and communication of the purpose, outcome, and potential clinical implications of genomic tests can be facilitated.

NPJ GENOMIC MEDICINE (2022)

Review Biochemistry & Molecular Biology

What matters to parents? A scoping review of parents' service experiences and needs regarding genetic testing for rare diseases

Erin Crellin, Melissa Martyn, Belinda McClaren, Clara Gaff

Summary: Patient care experiences play a crucial role in the successful implementation of genomics in paediatric care. A scoping review was conducted to understand parents' experiences and needs regarding genetic testing for rare diseases in their children. The review revealed that parents valued feeling cared for, consistent relationships with clinicians, empathic communication, updated information during the waiting period for test results, and access to support resources following result disclosure. Strategies to address unmet needs were proposed, but evidence on their effectiveness was limited. This emphasizes the need for rigorous interventions and the integration of genomics into paediatric care.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Genetics & Heredity

Investigating genomic medicine practice and perceptions amongst Australian non-genetics physicians to inform education and implementation

Amy Nisselle, Emily King, Bronwyn Terrill, Belinda Davey, Belinda McClaren, Kate Dunlop, Debra Graves, Sylvia Metcalfe, Clara Gaff

Summary: Genomic medicine is being implemented globally, and a genomic-competent health workforce is needed. A survey of Australian non-genetics physicians revealed that confidence and engagement with genomic medicine were influenced by factors such as specialty, continuing genomics education, and genomics research experience. Respondents who had completed genomics education and were engaged in genomic medicine reported higher confidence and were more likely to prefer genomic testing with genetics services support. A progression of genomic competence aligned with service delivery models and workplace learning could facilitate the adoption of genomic tests.

NPJ GENOMIC MEDICINE (2023)

Editorial Material Biochemistry & Molecular Biology

Rapid genomic testing in critically ill patients with genetic conditions: position statement by the Human Genetics Society of Australasia

Danya F. Vears, Fiona Lynch, Amy Nisselle, Samantha Ayres, Zornitza Stark

Summary: Rapid genomic testing is now considered the standard of care for critically ill children suspected of having an underlying genetic condition, and should be provided equally to all patients in acute care settings. The HGSA encourages the involvement of a multidisciplinary team, particularly genetic health professionals, in the delivery of rapid genomic testing services. Pre-test genetic counseling should be personalized to the needs of the family, and follow-up appointments should be offered. Informed consent for rapid genomic testing should be obtained, even in acute care settings. Rapid genomic testing should be conducted with minimal delay, preferably using whole genome sequencing. Incidental, secondary findings, and variants of uncertain significance should be reported cautiously. While the trio approach is recommended, infants or children should not be excluded from rapid genomic testing programs if biological parents are unavailable.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Review Genetics & Heredity

What's in a name? Justifying terminology for genomic findings beyond the initial test indication: A scoping review

Stephanie White, Matilda Haas, Kitty-Jean Laginha, Kirsten Laurendet, Clara Gaff, Danya Vears, Ainsley J. Newson

Summary: Genome sequencing can generate findings beyond the initial test indication, and a variety of terms are used globally to describe these findings. Justifications for term choices include the expectedness of the finding, effective communication, relatedness to the original test indication, and how genomic information was generated. Further work is needed to include the perspectives of patients in terminology choice.

GENETICS IN MEDICINE (2023)

Article Oncology

Workforce Implications of Increased Referrals to Hereditary Cancer Services in Canada: A Scenario-Based Analysis

Nick Dragojlovic, Kennedy Borle, Nicola Kopac, Amy Nisselle, Jennifer Nuk, Mandy Jevon, Jan M. Friedman, Alison M. Elliott, Larry D. Lynd, GenCOUNSEL Study

Summary: The utilization of clinical genetics services has rapidly increased in the past decade, leading to a shortage of healthcare providers in genetic healthcare. A workforce requirements model was developed to determine the future need for specialists and genetic counselors in Canada, especially in the field of hereditary cancer risk assessment. The model predicts a significant increase in the number of healthcare providers needed by 2030, highlighting the importance of innovative service delivery and mainstreaming of cancer genetics care in Canadian health systems.

CURRENT ONCOLOGY (2023)

No Data Available